TORONTO, Nov. 20 /CNW/ - Patheon (TSX:PTI), a global provider of drug
development and manufacturing services to the international pharmaceutical
industry, announced today that it has signed a master service agreement with
Omnicare Clinical Research, a leading global CRO, for distribution of clinical
trial materials in Europe and Asia Pacific.
